Showing results (71-80 of 148) with videos related to
Sort By:
Pageof 15
American Journal of Hematology|February 4, 2022
Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mappingKatrina Rack, Jolien De Bie, Geneviève Ameye, et al.Plos One|January 9, 2016
Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 SignalingSebastian K Wandinger, Idoya Lahortiga, Kris Jacobs, et al.Plos One|January 14, 2014
Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1Leila Rouhigharabaei, Julio Finalet Ferreiro, Thomas Tousseyn, et al.Gastroenterology|February 3, 2005
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutantsMaria Debiec-Rychter, Jan Cools, Herlinde Dumez, et al.Human Mutation|November 6, 2007
Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutationEllen Denayer, Annabel Parret, Magdalena Chmara, et al.Blood|March 23, 2012
Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemiaMichaël Porcu, Maria Kleppe, Valentina Gianfelici, et al.Leukemia|May 10, 2018
Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemiaJolien De Bie, Sofie Demeyer, Llucia Alberti-Servera, et al.BMC Biology|February 27, 2024
The cytoskeleton adaptor protein Sorbs1 controls the development of lymphatic and venous vessels in zebrafishAlexandra Veloso, Anouk Bleuart, Louise Conrard, et al.Science Translational Medicine|May 31, 2019
Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibitionRoger A Habets, Charles E de Bock, Lutgarde Serneels, et al.Blood|February 18, 2011
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphomaKatrien Van Roosbroeck, Luk Cox, Thomas Tousseyn, et al.Pageof 15